NEW YORK TIMES CO reported the quarter ended March 31, 2026 results: EPS $0.54.
“On May 6, 2026, The New York Times Company (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2026.”
NEW YORK TIMES CO — fact timeline
Source-grounded facts extracted from NEW YORK TIMES CO's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
NEW YORK TIMES CO reported financial results for the quarter ended March 31, 2024.
“On May 8, 2024, The New York Times Company (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2024.”
NEW YORK TIMES CO shareholders approved Advisory vote to approve executive compensation at the 2024-04-24 meeting.
“Proposal Number 3 — Advisory vote to approve executive compensation The Class B common stockholders approved the advisory resolution on the compensation of the Company’s named executive officers.”
NEW YORK TIMES CO shareholders approved Ratification of the selection of Ernst & Young LLP as auditors at the 2024-04-24 meeting.
“Proposal Number 2 — Ratification of the selection of Ernst & Young LLP as auditors The stockholders (with Class A and Class B common stockholders voting together) ratified the selection, by the Audit Committee of the Board of Directors, of Ernst & Young LLP, an independent registered public accounting firm, as auditors of the Company for the fiscal year ending December 31, 2024.”
NEW YORK TIMES CO shareholders approved Election of directors at the 2024-04-24 meeting.
“The annual meeting of stockholders of The New York Times Company (the “Company”) was held on April 24, 2024. At the annual meeting, the Company’s stockholders voted on three proposals and cast their votes as follows: Proposal Number 1 — Election of directors The stockholders (with Class A and Class B common stockholders voting separately) elected all of management’s nominees for election as directors.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.